• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
How to Explain the Current State of EKRA to Your Lab Executives

How to Explain the Current State of EKRA to Your Lab Executives

by Glenn S. Demby | Feb 24, 2023 | Brief Your CEO-lca, Essential, Lab Compliance Advisor, Reimbursement-lca

How to explain the current state of EKRA to your lab executives.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Lab Sales & Marketing Compliance: The Current State of EKRA

by Glenn S. Demby | Feb 9, 2023 | Enforcement-nir, Essential, National Lab Reporter

Sales and marketing operations liability risks and the measures labs should and shouldn’t take to manage those risks.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Clinical Laboratory Enforcement Update

Clinical Laboratory Enforcement Update

by G2 Intelligence Staff | Jan 23, 2023 | Webinars, webinars free

Get an overview of trending areas of enforcement and steps labs and pathology practices can consider to protect their businesses.

Court Refuses to Dismiss EKRA Charges against Former Arrayit CEO

Court Refuses to Dismiss EKRA Charges against Former Arrayit CEO

by Glenn S. Demby | Jun 22, 2022 | Essential, Lab Compliance Advisor, Labs in Court-lca

In this month’s Labs in Court roundup, Arrayit’s former president loses his bid to have EKRA charges dismissed, and more.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Did Commission Agreement based on Lab Client Revenues Violate EKRA?

Did Commission Agreement based on Lab Client Revenues Violate EKRA?

by Glenn S. Demby | Nov 30, 2021 | Articles, Essential, Lab Compliance Advisor, Labs in Court-lca

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com